|
WO1997049400A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
EP1000017A4
(en)
*
|
1997-07-29 |
2000-10-18 |
Smithkline Beecham Corp |
ANTAGONISTS OF THE IL-8 RECEPTOR
|
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
US20080300281A1
(en)
*
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
|
AU2234199A
(en)
*
|
1998-01-16 |
1999-08-02 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
UY25842A1
(es)
*
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
US20080269265A1
(en)
*
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
US7351834B1
(en)
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
IL144144A0
(en)
*
|
1999-01-13 |
2002-05-23 |
Bayer Ag |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
AR030689A1
(es)
*
|
2000-03-14 |
2003-09-03 |
Smithkline Beecham Corp |
Compuestos de 3-aminosulfonil-2-hidroxifenil urea, composiciones farmaceuticas que los comprenden, y uso de dichos compuestos en la manufactura de medicamentos para tratar enfermedades mediadas por quimioquinas
|
|
US6767922B2
(en)
|
2000-03-14 |
2004-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
JP2003527360A
(ja)
*
|
2000-03-14 |
2003-09-16 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８受容体アンタゴニスト
|
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
RU2344123C9
(ru)
*
|
2001-04-16 |
2009-05-20 |
Шеринг Корпорейшн |
3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс-хемокинового рецептора
|
|
US7371763B2
(en)
*
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
ES2393900T3
(es)
*
|
2001-12-03 |
2012-12-28 |
Bayer Healthcare Llc |
Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
|
|
AU2003210969A1
(en)
*
|
2002-02-11 |
2003-09-04 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenesis inhibiting activity
|
|
SI1478358T1
(sl)
|
2002-02-11 |
2013-09-30 |
Bayer Healthcare Llc |
Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
|
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
|
PT1580188E
(pt)
*
|
2002-02-11 |
2012-01-25 |
Bayer Healthcare Llc |
Aril-ureias como inibidores de cinases
|
|
TW200418812A
(en)
*
|
2002-10-29 |
2004-10-01 |
Smithkline Beecham Corp |
IL-8 receptor antagonists
|
|
US20060229335A1
(en)
*
|
2002-12-24 |
2006-10-12 |
Bradley Teegarden |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
JP4860474B2
(ja)
|
2003-05-20 |
2012-01-25 |
バイエル、ファーマシューテイカルズ、コーポレイション |
Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素
|
|
PL1558582T3
(pl)
|
2003-07-22 |
2006-05-31 |
Arena Pharm Inc |
Diarylowe i aryloheteroarylowe pochodne mocznika jako modulatory receptora serotoninowego 5-HT2A użyteczne w profilaktyce i w leczeniu zaburzeń związanych z tym receptorem
|
|
CL2004001834A1
(es)
|
2003-07-23 |
2005-06-03 |
Bayer Pharmaceuticals Corp |
Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
|
|
US7812176B2
(en)
*
|
2004-03-23 |
2010-10-12 |
Arena Pharmaceuticals, Inc. |
Processes for preparing substituted N-aryl-N′-[3-(1H-pyrazol-5-YL) phenyl] ureas and intermediates thereof
|
|
CN101010315A
(zh)
*
|
2004-04-30 |
2007-08-01 |
拜耳制药公司 |
用于治疗癌症的取代的吡唑基脲衍生物
|
|
AU2005245399A1
(en)
|
2004-05-12 |
2005-12-01 |
Schering Corporation |
CXCR1 and CXCR2 chemokine antagonists
|
|
JP2008517054A
(ja)
*
|
2004-10-20 |
2008-05-22 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８受容体アンタゴニスト
|
|
SA05260357B1
(ar)
*
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
|
|
US20080015223A1
(en)
*
|
2004-12-03 |
2008-01-17 |
Arena Pharmaceuticals, Inc. |
Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
|
|
CA2594563A1
(en)
*
|
2005-01-19 |
2006-07-27 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
|
|
EP1851188A1
(en)
*
|
2005-02-22 |
2007-11-07 |
Teva Pharmaceutical Industries Limited |
Improved process for the synthesis of enantiomeric indanylamine derivatives
|
|
CN101472477B
(zh)
*
|
2006-04-21 |
2013-02-20 |
史密丝克莱恩比彻姆公司 |
Il-8受体拮抗剂
|
|
EP2010180A4
(en)
|
2006-04-21 |
2010-10-13 |
Glaxosmithkline Llc |
IL-8 RECEPTOR ANTAGONISTS
|
|
WO2007136703A1
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
SG171681A1
(en)
|
2006-05-18 |
2011-06-29 |
Arena Pharm Inc |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
|
|
EP3395816A1
(en)
|
2006-05-18 |
2018-10-31 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
CL2007001829A1
(es)
*
|
2006-06-23 |
2008-01-25 |
Smithkline Beecham Corp |
P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
|
|
TWI415845B
(zh)
*
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
ES2421237T7
(es)
|
2007-08-15 |
2013-09-30 |
Arena Pharmaceuticals, Inc. |
Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
|
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
SMT201800199T1
(it)
|
2008-10-28 |
2018-05-02 |
Arena Pharm Inc |
Composizioni di un modulatore dei recettori della serotonina 5-ht2a utili per il trattamento di disturbi correlati a esso
|
|
WO2011075596A1
(en)
|
2009-12-18 |
2011-06-23 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
CN109562085A
(zh)
|
2015-06-12 |
2019-04-02 |
阿速万科学有限责任公司 |
用于预防和治疗rem睡眠行为障碍的二芳基和芳基杂芳基脲衍生物
|
|
TW201720439A
(zh)
|
2015-07-15 |
2017-06-16 |
Axovant Sciences Gmbh |
用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物
|